IN-VITRO CYTOTOXICITY AGAINST HUMAN CANCER CELL-LINES DURING PULSED MAGNETIC-FIELD EXPOSURE

被引:0
|
作者
HANNAN, CJ
LIANG, YY
ALLISON, JD
SEARLE, JR
机构
[1] MED COLL GEORGIA,BIOENGN SECT,AUGUSTA,GA 30912
[2] VET ADM MED CTR,RES SERV,AUGUSTA,GA 30910
[3] VET ADM MED CTR,NUCL MED SERV,AUGUSTA,GA 30910
关键词
EXPERIMENTAL THERAPEUTICS; CISPLATIN; CARBOPLATIN; DAUNORUBICIN; PULSED MAGNETIC FIELD; CHEMOTHERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In an in vitro cell growth assay, carboplatin potency against A-431 cells increased after a 1 hour PMF (pulsed magnetic field) exposure (calculated peak field 5.2 mTesla, with an average field strength of 0.525 mTesla(rms); pulses rose for 120 mu sec and then abruptly fell to neutral and, were repeated at a rare of too ol 250 pulses per second). This potentiating effect was not observed with cisplatin or daunomycin. When cytotoxicity against HT-29 cells was measured, PMF exposure potentiated both cal boplatin and daunomycin, but again, not cisplatin. Both cell types exhibited increased growth when exposed only to PMF. Exposure to PMF consistently increased the cell growth of these cancer cell lines, while only some in vitro antineoplastic agents were potentiated by PMFs.
引用
收藏
页码:1517 / 1520
页数:4
相关论文
共 50 条
  • [21] The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro
    Hu, K
    Yao, XS
    [J]. ANTICANCER RESEARCH, 2002, 22 (2A) : 1001 - 1005
  • [22] Synthesis and in vitro cytotoxicity of some ruthenium(II) complexes against human cancer cell lines
    Mazumder, UK
    Gupta, M
    Bhattacharya, S
    Karki, SS
    Manikandan, L
    Roy, M
    Chakraborty, S
    Suresh, R
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 213 - 213
  • [23] Evaluation of Cassia occidentalis for in vitro cytotoxicity against human cancer cell lines and antibacterial activity
    Bhagat, Madhulika
    Saxena, Ajit Kumar
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (04) : 234 - 237
  • [24] 2 HUMAN BREAST-CANCER CELL-LINES SHOWING DECREASING TELOMERIC REPEAT LENGTH DURING EARLY IN-VITRO PASSAGING
    ROGALLA, P
    KAZMIERCZAK, B
    ROHEN, C
    TRAMS, G
    BARTNITZKE, S
    BULLERDIEK, J
    [J]. CANCER GENETICS AND CYTOGENETICS, 1994, 77 (01) : 19 - 25
  • [25] IN-VITRO EFFECTS OF RECOMBINANT HUMAN INTERFERON-GAMMA ON HUMAN MESOTHELIOMA CELL-LINES
    ZENG, L
    BUARD, A
    MONNET, I
    BOUTIN, C
    FLEURY, J
    SAINTETIENNE, L
    BROCHARD, P
    BIGNON, J
    JAURAND, MC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (03) : 515 - 520
  • [26] INHIBITORY EFFECTS OF CHOLERA-TOXIN ON IN-VITRO GROWTH OF HUMAN LUNG-CANCER CELL-LINES
    KIURA, K
    WATARAI, S
    SHIBAYAMA, T
    OHNOSHI, T
    KIMURA, I
    YASUDA, T
    [J]. ANTI-CANCER DRUG DESIGN, 1993, 8 (06): : 417 - 428
  • [27] INFECTION OF HUMAN HEPATOCYTE CELL-LINES WITH HEPATITIS-C VIRUS IN-VITRO
    TAGAWA, M
    KATO, N
    YOKOSUKA, O
    ISHIKAWA, T
    OHTO, M
    OMATA, M
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (05) : 523 - 527
  • [28] ACTIVITY OF PLATINUM DRUGS AGAINST MELANOMA CELL-LINES - IS IT MODULATED IN-VITRO IN THE PRESENCE OF TAMOXIFEN
    MOHAMMED, MQ
    PHOTIOU, A
    SHAH, P
    RETSAS, S
    [J]. ANTICANCER RESEARCH, 1995, 15 (04) : 1319 - 1326
  • [29] SHIELDED CULTURE CHAMBER AND CONTROLLED UNIAXIAL MAGNETIC-FIELD GENERATOR FOR VERY-LOW FREQUENCY (VLF) MAGNETIC-FIELD EXPOSURE OF CELLS DURING IN-VITRO CULTURE
    LAMONT, JW
    WEBER, RJ
    DOOLEY, MP
    PINEDA, MH
    MOYE, DJ
    [J]. FASEB JOURNAL, 1994, 8 (04): : A398 - A398
  • [30] STABLE ANALOGS OF THE ANTITUMOR AGENT TRIMELAMOL RETAIN IN-VITRO CYTOTOXICITY IN DRUG-SENSITIVE AND RESISTANT RODENT AND HUMAN CELL-LINES
    COLEY, HM
    JARMAN, M
    BROOKS, N
    THORNTON, TJ
    JUDSON, IR
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1827 - 1836